Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Fiche publication
Date publication
décembre 2013
Journal
Seminars in arthritis and rheumatism
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Hiligsmann M, Cooper C, Arden N, Boers M, Branco JC, Luisa Brandi M, Bruyère O, Guillemin F, Hochberg MC, Hunter DJ, Kanis JA, Kvien TK, Laslop A, Pelletier JP, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Tsouderos Y, Tugwell P, Reginster JY
Lien Pubmed
Résumé
There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy.
Mots clés
Consensus, Cost of Illness, Cost-Benefit Analysis, Evidence-Based Medicine, economics, Humans, Osteoarthritis, economics, Quality of Life
Référence
Semin. Arthritis Rheum.. 2013 Dec;43(3):303-13